Education
About Us
Working with TipRanks
Follow Us
Pulse Biosciences Inc (PLSE)
:PLSE
PLSE Stock Chart & Stats
$18.21
-$0.27(-1.46%)
At close: 4:00 PM EST
$18.21
-$0.27(-1.46%)
Day’s Range― - ―
52-Week Range$13.77 - $25.00
Previous CloseN/A
Volume31.18K
Average Volume (3M)189.59K
Market Cap
$1.14B
Enterprise Value$917.09M
Total Cash (Recent Filing)$106.35M
Total Debt (Recent Filing)$8.24M
Price to Earnings (P/E)―
Beta1.85
Next Earnings
Nov 05, 2025EPS Estimate
-0.31Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.20
Shares Outstanding67,295,845
10 Day Avg. Volume126,741
30 Day Avg. Volume189,586
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market Cap0.81
Enterprise Value/Revenue551.14
Enterprise Value/Gross Profit61.14K
Enterprise Value/Ebitda-13.05
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Pulse Biosciences News
PLSE FAQ
What was Pulse Biosciences Inc’s price range in the past 12 months?
Pulse Biosciences Inc lowest stock price was $13.77 and its highest was $25.00 in the past 12 months.
What is Pulse Biosciences Inc’s market cap?
Pulse Biosciences Inc’s market cap is $1.14B.
When is Pulse Biosciences Inc’s upcoming earnings report date?
Pulse Biosciences Inc’s upcoming earnings report date is Nov 05, 2025 which is in 4 days.
How were Pulse Biosciences Inc’s earnings last quarter?
Pulse Biosciences Inc released its earnings results on Aug 12, 2025. The company reported -$0.199 earnings per share for the quarter, beating the consensus estimate of -$0.26 by $0.061.
Is Pulse Biosciences Inc overvalued?
According to Wall Street analysts Pulse Biosciences Inc’s price is currently Overvalued.
Does Pulse Biosciences Inc pay dividends?
Pulse Biosciences Inc does not currently pay dividends.
What is Pulse Biosciences Inc’s EPS estimate?
Pulse Biosciences Inc’s EPS estimate is -0.31.
How many shares outstanding does Pulse Biosciences Inc have?
Pulse Biosciences Inc has 67,295,845 shares outstanding.
What happened to Pulse Biosciences Inc’s price movement after its last earnings report?
Pulse Biosciences Inc reported an EPS of -$0.199 in its last earnings report, beating expectations of -$0.26. Following the earnings report the stock price went up 11.192%.
Which hedge fund is a major shareholder of Pulse Biosciences Inc?
Currently, no hedge funds are holding shares in PLSE
Pulse Biosciences Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Blogger Sentiment
Bullish
PLSE Sentiment 70%
Sector Average ―
Sector Average ―
Hedge Fund Trend
Increased
By 22.0K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Bought Shares
Worth $2.8M over
the Last 3 Months
the Last 3 Months
Technicals
SMA
Positive
20 days / 200 days
Momentum
0.41%
12-Months-Change
Fundamentals
Return on Equity
-103.50%
Trailing 12-Months
Asset Growth
197.44%
Trailing 12-Months
Company Description
Pulse Biosciences Inc
Pulse Biosciences, Inc. is a medical technology company that focuses on developing and commercializing innovative therapeutic treatments leveraging its proprietary Nano-Pulse Stimulation (NPS) technology. Operating within the healthcare and medical device sectors, Pulse Biosciences aims to provide non-thermal, cellular-specific treatments for a range of dermatological and oncological conditions. The company's core product, the CellFX System, is designed to deliver precise energy pulses to treat benign and malignant lesions on the skin.
PLSE Earnings Call
Q2 2025
0:00 / 0:00
Earnings Call Sentiment|Neutral
Pulse Biosciences reported significant progress in its market development programs and positive clinical outcomes, particularly in soft tissue ablation and cardiac device development. However, the company faces rising operating expenses and net losses, along with expected increases in cash use. Despite these challenges, the company's strong cash position and upcoming revenue generation provide a positive outlook.View all PLSE earnings summariesTechnical Analysis
Ownership Overview
74.19% Insiders
2.57% Mutual Funds
0.38% Other Institutional Investors
20.15% Public Companies and
Individual Investors